Tannaz Armaghany

652 total citations
8 papers, 406 citations indexed

About

Tannaz Armaghany is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Tannaz Armaghany has authored 8 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Tannaz Armaghany's work include Head and Neck Cancer Studies (2 papers), Lung Cancer Research Studies (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Tannaz Armaghany is often cited by papers focused on Head and Neck Cancer Studies (2 papers), Lung Cancer Research Studies (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Tannaz Armaghany collaborates with scholars based in United States and Egypt. Tannaz Armaghany's co-authors include Jon D. Wilson, Glenn Mills, Shobana Sekar, Paul Fredlund, Sean C. Semple, Michael J. Demeure, David C. Smith, John D. Carpten, Aymen Elfiky and Mark Kowalski and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Epidemiology Biomarkers & Prevention and PubMed.

In The Last Decade

Tannaz Armaghany

8 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tannaz Armaghany United States 5 191 188 130 114 47 8 406
Kari Trumpi Netherlands 9 257 1.3× 222 1.2× 111 0.9× 173 1.5× 44 0.9× 13 482
Huayi Huang United States 13 217 1.1× 167 0.9× 87 0.7× 102 0.9× 56 1.2× 31 488
Tanner J. Freeman United States 8 238 1.2× 136 0.7× 54 0.4× 95 0.8× 44 0.9× 13 446
Xiangming Xu China 8 305 1.6× 171 0.9× 75 0.6× 123 1.1× 47 1.0× 16 495
Li Weng United States 11 312 1.6× 120 0.6× 77 0.6× 77 0.7× 46 1.0× 21 514
Alice E. Shin United States 4 171 0.9× 158 0.8× 51 0.4× 93 0.8× 70 1.5× 6 374
Kurt Buchegger Chile 11 262 1.4× 135 0.7× 93 0.7× 162 1.4× 61 1.3× 27 458
Enrico Duranti Italy 11 197 1.0× 213 1.1× 62 0.5× 92 0.8× 80 1.7× 18 404
Lyndsay Willmott United States 10 136 0.7× 129 0.7× 49 0.4× 58 0.5× 31 0.7× 36 381

Countries citing papers authored by Tannaz Armaghany

Since Specialization
Citations

This map shows the geographic impact of Tannaz Armaghany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tannaz Armaghany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tannaz Armaghany more than expected).

Fields of papers citing papers by Tannaz Armaghany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tannaz Armaghany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tannaz Armaghany. The network helps show where Tannaz Armaghany may publish in the future.

Co-authorship network of co-authors of Tannaz Armaghany

This figure shows the co-authorship network connecting the top 25 collaborators of Tannaz Armaghany. A scholar is included among the top collaborators of Tannaz Armaghany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tannaz Armaghany. Tannaz Armaghany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hatia, Rikita, Ernest T. Hawk, Ahmed Shalaby, et al.. (2023). Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1338–1347. 2 indexed citations
2.
Smaglo, Brandon G., Benjamin Musher, Spyridoula Vasileiou, et al.. (2020). A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy and adoptively transferred nonengineered, multiantigen specific T cells in the first-line setting (TACTOPS).. Journal of Clinical Oncology. 38(15_suppl). 4622–4622. 10 indexed citations
3.
Demeure, Michael J., Tannaz Armaghany, Samuel Ejadi, et al.. (2016). A phase I/II study of TKM-080301, a PLK1-targeted RNAi in patients with adrenocortical cancer (ACC).. Journal of Clinical Oncology. 34(15_suppl). 2547–2547. 45 indexed citations
4.
Armaghany, Tannaz, et al.. (2015). Treatment of high grade metastatic neuroendocrine tumor (mNET) with peptide receptor radionuclide therapy (PRRT): Retrospective analysis in a single referral center.. Journal of Clinical Oncology. 33(15_suppl). e15175–e15175. 6 indexed citations
5.
Peddi, Prakash, Runhua Shi, Cherie‐Ann O. Nathan, et al.. (2012). Cisplatin (CDDP) and radiation versus cetuximab (Cx) and radiation in locally advanced head and neck squamous cell cancer (SCHNC): A retrospective review.. Journal of Clinical Oncology. 30(15_suppl). e16009–e16009. 2 indexed citations
6.
Armaghany, Tannaz, et al.. (2012). Genetic alterations in colorectal cancer.. PubMed. 5(1). 19–27. 334 indexed citations
7.
Armaghany, Tannaz, et al.. (2012). Solitary Brain Metastasis in a Patient With Ovarian Cancer With BRCA2 Mutation. Journal of Clinical Oncology. 30(25). e239–e240. 5 indexed citations
8.
Armaghany, Tannaz, et al.. (2009). Effect of insurance status and distance from treatment center on the overall survival of patients with non-small cell lung caner treated in an academic center. Journal of Clinical Oncology. 27(15_suppl). e17557–e17557. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026